NASDAQ:BILIBilibili Stock Price, Forecast & News

Bilibili's stock was trading at $25.67 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BILI stock has increased by 87.7% and is now trading at $48.18. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bilibili in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Bilibili.

Bilibili is scheduled to release its next quarterly earnings announcement on Monday, August 24th 2020. View our earnings forecast for Bilibili.

Bilibili Inc - (NASDAQ:BILI) issued its quarterly earnings results on Monday, May, 18th. The company reported ($1.43) EPS for the quarter, missing the Zacks' consensus estimate of ($0.16) by $1.27. The firm had revenue of $327.02 million for the quarter. Bilibili had a negative return on equity of 20.37% and a negative net margin of 21.20%. View Bilibili's earnings history.

10 equities research analysts have issued 1 year price objectives for Bilibili's shares. Their forecasts range from $17.90 to $42.00. On average, they expect Bilibili's share price to reach $30.99 in the next year. This suggests that the stock has a possible downside of 35.7%. View analysts' price targets for Bilibili.

Media headlines about BILI stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Bilibili earned a coverage optimism score of -1.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Bilibili.

Some companies that are related to Bilibili include Workday (WDAY), Verisk Analytics (VRSK), RingCentral (RNG), PagSeguro Digital (PAGS), StoneCo (STNE), Zendesk (ZEN), Autohome (ATHM), Zynga (ZNGA), Clarivate Analytics (CCC), Pegasystems (PEGA), YY (YY), Five9 (FIVN), Proofpoint (PFPT), Globant (GLOB) and Corelogic (CLGX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bilibili investors own include Alibaba Group (BABA), IQIYI (IQ), NVIDIA (NVDA), JD.Com (JD), Baidu (BIDU), Advanced Micro Devices (AMD), Square (SQ), HUYA (HUYA), TENCENT HOLDING/ADR (TCEHY) and Baozun (BZUN).

(BILI) raised $483 million in an initial public offering on Wednesday, March 28th 2018. The company issued 42,000,000 shares at $10.50-$12.50 per share. Morgan Stanley, BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO.

Bilibili trades on the NASDAQ under the ticker symbol "BILI."

Bilibili's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Modus Advisors LLC (0.00%).

BILI stock was purchased by a variety of institutional investors in the last quarter, including Modus Advisors LLC.

Shares of BILI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BILI stock can currently be purchased for approximately $48.18.

Bilibili has a market capitalization of $15.71 billion and generates $973.59 million in revenue each year. The company earns $-185,150,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. Bilibili employs 4,791 workers across the globe.

The official website for Bilibili is www.bilibili.com.

Bilibili's mailing address is 17TH FLOOR BUILDING 3 GUOZHENG CENTER NO. 485 ZHENGLI ROAD YANGPU DISTRICT, SHANGHAI F4, 200433. The company can be reached via phone at 86-21-2509-9255.